Expression of chloride channel protein CLC-3 in patients with allergic rhinitis: Effect of topical corticosteroid treatment

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 3, 2008, Pages 301-305

  Li, Huabin ^a,b   Wen, Weiping ^a   Cheng, Lei ^b   Shi, Jianbo ^a   Jiang, Hongyan ^a   Oh, Yun ^c   Xu, Geng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; CLC 3 PROTEIN; MOMETASONE FUROATE; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE MUCOSA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; SUBMUCOSA; UPREGULATION;

ADMINISTRATION, TOPICAL; ADULT; ANTI-ALLERGIC AGENTS; CHLORIDE CHANNELS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NASAL MUCOSA; PREGNADIENEDIOLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS, ALLERGIC, PERENNIAL; STATISTICS, NONPARAMETRIC; UP-REGULATION;

EID: 41149153382     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2007.45     Document Type: Article

References (21)

1. Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5)(suppl):S147- S334.
2. Jang YJ, Lee CH. Localization of cystic fibrosis transmembrane conductance regulator in epithelial cells of nasal polyps and postoperative polypoid mucosae. Acta Otolaryngol. 2001;121(1):93-97.
3. Jentsch TJ, Poet M, Fuhrmann JC, et al. Physiological functions of CLC Cl- channels gleaned from human genetic disease and mouse models. Annu Rev Physiol. 2005;67:779-807.
4. Chinet TC, Fullton JM, Yankaskas JR, Boucher RC, Stutts MJ. Sodiumpermeable channels in the apical membrane of human nasal epithelial cells. Am J Physiol. 1993;265(4, pt 1):C1050-C1060.
5. Bernstein JM, Gorfien J, Noble B, et al. Nasal polyposis: immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps). J Allergy Clin Immunol. 1997;99(2):165-175.
6. Lipecka J, Bali M, Thomas A, et al. Distribution of ClC-2 chloride channel in rat and human epithelial tissues. Am J Physiol Cell Physiol. 2002;282(4):C805-C816.
7. Oshima T, Ikeda K, Furukawa M. Expression of the voltage-dependent chloride channel ClC-3 in human nasal tissue. ORL J Otorhinolaryngol Relat Spec. 2001; 63(2):82-86.
8. Rose MC, Nickola TJ, Voynow JA. Airway mucus obstruction: mucin glycoproteins, MUC gene regulation and goblet cell hyperplasia. Am J Respir Cell Mol Biol. 2001;25(5):533-537.
9. Bernstein JM, Yankaskas JR. Increased ion transport in cultured nasal polyp epithelial cells. Arch Otolaryngol Head Neck Surg. 1994;120(9):993-996.
10. Towne JE, Harrod KS, Krane CM, et al. Decreased expression of aquaporin (AQP)1 and AQP5 in mouse lung after acute viral infection. Am J Respir Cell Mol Biol. 2000;22(1):34-44.
11. Song Y, Sonawane N, Verkman AS. Localization of aquaporin-5 in sweat glands and functional analysis using knockout mice. J Physiol. 2002;541(pt 2):561-568.
12. Quinton PM. Cystic fibrosis: a disease in electrolyte transport. FASEB J. 1990;4 (10):2709-2717.
13. Zhang X, Guo Y, Dong Z, et al. Sodium channels in the apical membrane of human nasal epithelial cells. Chin Med J (Engl). 2001;114(3):313-316.
14. Fahlke C. Ion permeation and selectivity in ClC-type chloride channels. Am J Physiol Renal Physiol. 2001;280(5):F748-F757.
15. Valverde MA, Hardy SP, Sepulveda FV. Chloride channels: a state of flux. FASEB J. 1995;9(7):509-515.
16. Han DM, Zhou B, Cheng L, Oh Y, Li H. p38 MAP-kinase is involved in the production of CLC-3 production in nasal epithelial cells with allergic rhinitis induced by interleukin-4. Laryngoscope. 2006;116(11):1973-1977.
17. Naclerio RM. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol. 1988;82(5, pt 2):927-934.
18. Mygind N, Nielsen LP, Hoffmann HJ, et al. Mode of action of intranasal corticosteroids. J Allergy Clin Immunol. 2001;108(1)(suppl):S16-S25.
19. Berger WE, Nayak AS, Staudinger HW. Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis. Ann Pharmacother. 2005;39(12):1984-1989.
20. Patel RS, Shaw SR, Wallace AM, et al. Efficacy and systemic tolerability of mometasone furoate and betamethasone sodium phosphate. J Laryngol Otol. 2004;118(11):866-871.
21. Rogers DF. Airway hypersecretion in allergic rhinitis and asthma: new pharmacotherapy. Curr Allergy Asthma Rep. 2003;3(3):238-248.